We conclude that PROX1 is a new prognostic biomarker for 1p19q non-codeleted high-grade astrocytomas that have progressed from pre-existing low-grade tumors and harbor IDH mutations. The gene discussed is IDH1; the disease is astrocytoma (excluding glioblastoma).